Back
Vertex Pharmaceuticals Vs. Innodata Industry Stock Comparison
Buy
61
VRTX
Vertex Pharmaceuticals
Last Price:
$503.04
Seasonality Move:
11.16%
Buy
51
INOD
Innodata
Last Price:
$43.15
Seasonality Move:
9.95%
Buy
61
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $502.92. The Score for VRTX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $502.92Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight buying pressure.
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 11.11 | Buy |
Relative Strength Index (14 RSI): | 65.64 | Buy |
Chaikin Money Flow: | 349579 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (465.81 - 490.61) | Buy |
Bollinger Bands (100): | (429.8 - 488.48) | Buy |
INOD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 44.5 | Sell |
Chaikin Money Flow: | -838391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.39 - 56.81) | Sell |
Bollinger Bands (100): | (28.15 - 49.55) | Buy |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 490.23 | Buy |
20-day SMA: | 478.2 | Buy |
50-day SMA: | 450.84 | Buy |
200-day SMA: | 467.29 | Buy |
8-day EMA: | 490.81 | Buy |
20-day EMA: | 480.4 | Buy |
50-day EMA: | 465.65 | Buy |
200-day EMA: | 453.48 | Buy |
INOD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.61 | Sell |
20-day SMA: | 51.75 | Sell |
50-day SMA: | 44 | Sell |
200-day SMA: | 27.42 | Buy |
8-day EMA: | 47.25 | Sell |
20-day EMA: | 48.54 | Sell |
50-day EMA: | 44.99 | Sell |
200-day EMA: | 30.74 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.43 per share, an increase next quarter of $0.09 per share, an increase this year of $17.58 per share, and an increase next year of $2.24 per share.
Innodata Earnings Growth & INOD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.03 per share, and an increase next year of $0.36 per share.
Vertex Pharmaceuticals Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Innodata Technical Analysis
Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |